Recombinant Rat FASN Protein Pre-coupled Magnetic Beads

• Cat.No.: FASN-1932R-B
• Product Overview: The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations.

Specification

• Source: HEK293
• Species: Rat
• Form: Solution
• Particle size: ~2 μm
• Beads Surface: Hydrophilic
• Capacity: > 200 pmol rabbit IgG/ mg beads
• Applications: Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification.
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions.
• Storage: 2-8℃. Do not to freeze thaw the Beads
• Concentration: 10mg beads/mL
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Fasn fatty acid synthase [ Rattus norvegicus ]
• Official Symbol: FASN
• Gene ID: 50671
• mRNA Refseq: NM_017332.1
• Protein Refseq: NP_059028.1
• UniProt ID: P12785

Reviews

12/13/2022

Its high quality and purity ensure accurate and reliable results.

07/26/2017

With the manufacturer's unwavering dedication to delivering quality products and unparalleled technical support, I am confident in their ability to help me overcome any challenges and propel my research forward.

06/20/2017

The FASN protein exhibits several valuable attributes that make it an excellent choice for my trials.

Q&As

Are there any ongoing clinical trials targeting FASN for therapeutic purposes?

Yes, several clinical trials are investigating FASN inhibitors as potential treatments for cancer and metabolic disorders.

How does FASN relate to insulin resistance and diabetes?

FASN has been associated with insulin resistance, and its inhibition is being investigated as a potential avenue for treating insulin resistance and type 2 diabetes.

Can FASN inhibitors be used in combination with other cancer therapies?

Combination therapies involving FASN inhibitors and other anticancer drugs are being explored to enhance treatment efficacy and reduce potential resistance.

How does FASN influence the development and progression of obesity?

FASN is involved in the synthesis of fatty acids, and its dysregulation can contribute to excessive fat accumulation, potentially leading to obesity.

Does FASN play a role in neurodegenerative diseases?

Emerging research suggests a potential link between FASN and neurodegenerative diseases, but more studies are needed to fully understand this connection.